Metabolic engineering of bacterial strains using CRISPR/Cas9 systems for biosynthesis of value-added products

被引:26
|
作者
Fokum, Ernest [1 ]
Zabed, Hossain M. [1 ]
Guo, Qi [1 ]
Yun, Junhua [1 ]
Yang, Miaomiao [1 ]
Pang, Hao [2 ]
An, Yingfeng [3 ]
Li, Wen [1 ]
Qi, Xianghui [1 ,2 ]
机构
[1] Jiangsu Univ, Sch Food Sci & Biol Engn, Zhenjiang 212013, Jiangsu, Peoples R China
[2] Guangxi Acad Sci, Guangxi Key Lab Biorefinery, Nanning 530007, Peoples R China
[3] Shenyang Agr Univ, Coll Biosci & Biotechnol, Shenyang 110161, Liaoning, Peoples R China
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
CRISPR/Cas9; Value-added ingredients; Bacterial genome editing; Strain improvement; Microbial biosynthesis; SEQUENCE-SPECIFIC CONTROL; ESCHERICHIA-COLI; GENE-EXPRESSION; INTERFERENCE CRISPRI; BACILLUS-SUBTILIS; GENOME; REPRESSION; BIOTRANSFORMATION; 1,3-PROPANEDIOL; DEHYDROGENASE;
D O I
10.1016/j.fbio.2019.01.003
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Metabolically engineered bacterial strains are fast becoming the center of attraction in the biosynthesis of various bio-based ingredients. Currently, CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) with its associated RNA guided endonuclease (Cas9), is considered as the most promising tool that has brought a breakthrough in the genome editing approach. Although this versatile system originates from the immune systems of bacteria, its application in bacterial genome editing as an approach of metabolic engineering is still not so extensive. This review paper discusses the challenges, opportunities and application of CRISPR/Cas system in bacterial genome editing for biosynthesis of various value-added ingredients. The content of this paper mainly emphasizes Type II CRISPR/Cas9 system used for knock-in and knock-out of various target genes in the bacterial strains as a pre-requisite for increasing the production of bio-based materials.
引用
收藏
页码:125 / 132
页数:8
相关论文
共 41 条
  • [31] Loss in the Antibacterial Ability of a PyrR Gene Regulating Pyrimidine Biosynthesis after Using CRISPR/Cas9-Mediated Knockout for Metabolic Engineering in Lactobacillus casei
    Chen, Shaojun
    He, Xinmiao
    Qin, Ziliang
    Li, Gang
    Wang, Wentao
    Nai, Zida
    Tian, Yaguang
    Liu, Di
    Jiang, Xinpeng
    MICROORGANISMS, 2023, 11 (10)
  • [32] Genome centric engineering using ZFNs, TALENs and CRISPR-Cas9 systems for trait improvement and disease control in Animals
    Wani, Atif Khurshid
    Akhtar, Nahid
    Singh, Reena
    Prakash, Ajit
    Raza, Sayed Haidar Abbas
    Cavalu, Simona
    Chopra, Chirag
    Madkour, Mahmoud
    Elolimy, Ahmed
    Hashem, Nesrein M.
    VETERINARY RESEARCH COMMUNICATIONS, 2023, 47 (01) : 1 - 16
  • [33] Metabolic engineering of Escherichia coli BL21 strain using simplified CRISPR-Cas9 and asymmetric homology arms recombineering
    Shukal, Sudha
    Lim, Xiao Hui
    Zhang, Congqiang
    Chen, Xixian
    MICROBIAL CELL FACTORIES, 2022, 21 (01)
  • [34] Efficient genome editing using CRISPR/Cas9 technology and its application for identifying Sesquiterpene synthases involved in the biosynthesis of Steperoxides in Steccherinum ochraceum
    Shen, Jia-Yu
    Mao, Fei-Hong
    Wang, Qiwen
    Ou, Pei-Pei
    Liu, Ji-Kai
    Zhao, Qunfei
    He, Qing-Li
    FUNGAL GENETICS AND BIOLOGY, 2024, 175
  • [35] Metabolic engineering of Escherichia coli BW25113 for the production of 5-Aminolevulinic Acid based on CRISPR/Cas9 mediated gene knockout and metabolic pathway modification
    Changchuan Ye
    Yuting Yang
    Xi Chen
    Lijie Yang
    Xia Hua
    Mengjie Yang
    Xiangfang Zeng
    Shiyan Qiao
    Journal of Biological Engineering, 16
  • [36] Optimization of scleroglucan production by Sclerotium rolfsii by lowering pH during fermentation via oxalate metabolic pathway manipulation using CRISPR/Cas9
    Bai T.
    Wang T.
    Li Y.
    Gao N.L.
    Zhang L.
    Chen W.-H.
    Yin X.
    Fungal Biology and Biotechnology, 8 (1)
  • [37] Genome centric engineering using ZFNs, TALENs and CRISPR-Cas9 systems for trait improvement and disease control in Animals
    Atif Khurshid Wani
    Nahid Akhtar
    Reena Singh
    Ajit Prakash
    Sayed Haidar Abbas Raza
    Simona Cavalu
    Chirag Chopra
    Mahmoud Madkour
    Ahmed Elolimy
    Nesrein M. Hashem
    Veterinary Research Communications, 2023, 47 : 1 - 16
  • [38] Modeling Host-Virus Interactions in Viral Infectious Diseases Using Stem-Cell-Derived Systems and CRISPR/Cas9 Technology
    Kim, Jihoon
    Koo, Bon-Kyoung
    Yoon, Ki-Jun
    VIRUSES-BASEL, 2019, 11 (02):
  • [39] Metabolic engineering of Escherichia coli BL21 strain using simplified CRISPR-Cas9 and asymmetric homology arms recombineering
    Sudha Shukal
    Xiao Hui Lim
    Congqiang Zhang
    Xixian Chen
    Microbial Cell Factories, 21
  • [40] Comparison of genome engineering using the CRISPR-Cas9 system in C. glabrata wild-type and lig4 strains
    Cen, Yuke
    Timmermans, Bea
    Souffriau, Ben
    Thevelein, Johan M.
    Van Dijck, Patrick
    FUNGAL GENETICS AND BIOLOGY, 2017, 107 : 44 - 50